SIETES :: 93212 citas

Resultados de la búsqueda por GOTAS OCULARES REFINAR BÚSQUEDA

1.

Yang M-S, Lee JY, Kim J, Kim G-W, Kim B-K, Kim Y, Park H-W, Cho S-H, Min K-U, Kang H-R. Searching for the culprit drugs for Stevens-Johnson syndrome and toxic epidermal necrolysis from a nationwide claim database in Korea. J Allergy Clin Immunol 2020;8:febrero. [Ref.ID 103535]

2.

Anónimo. Towards better patient care: drugs to avoid in 2019. Prescrire Int 2019;39:abril. [Ref.ID 103075]

3.

Silverman E. Allergan’s deal with the Mohawks raises troubling questions about the future of generics. STAT 2017:1. [Ref.ID 102047]

4.

Kmietowicz Z. Pfizer and Allergan agree $160bn merger deal. BMJ 2015;351:h6342. [Ref.ID 99704]

5.

Anónimo. Latanoprost (Xalatan): increased reporting of eye irritation since reformulation. Drug Safety Update 2015;8:2. [Ref.ID 99273]

6.

Anónimo. Glaucome chronique à angle ouvert. Prescrire 2015;35:123-5. [Ref.ID 98920]

7.

Giuliari GP. Intravitreal triamcinolone for diabetic macular edema. N Engl J Med 2010;363:2351. [Ref.ID 89768]

8.

Scott G. Over the counter chloramphenicol eye drops. BMJ 2010;340:724. [Ref.ID 88207]

9.

Anónimo. What are excipients doing in medicinal products?. Drug Ther Bull 2009;47:81-4. [Ref.ID 86136]

10.

Chadha V, Cruickshank I, Swingler R, Sanders R. Advanced glaucomatous visual loss and oral steroids. BMJ 2008;337:1168-70. [Ref.ID 84544]

11.

Anónimo. Ophthalmic azithromycin (AzaSite). Med Lett Drugs Ther 2008;50:11-2. [Ref.ID 82259]

12.

Anónimo. Vioxx charges mean fourth-quarter loss for Merck & Co. Scrip 2008;3333:12. [Ref.ID 82134]

13.

Spratt A, Ogunbowale L, Wormald R, Franks W. What's in a name? New glaucoma drugs. Lancet 2006;368:826-7. [Ref.ID 77861]

14.

Ngondi J, Onsarigo A, Matthews F, Reacher M, Brayne C, Baba S, Solomon AW, Zingeser J, Emerson PM. Effect of three years of SAFE (surgery, antibiotics, facial cleanliness, and environmental change) strategy for trachoma control in southern Sudan: a cross-sectional study. Lancet 2006;368:589-95. [Ref.ID 77813]

15.

Saha N. Antibiotics for acute infective conjunctivitis in children. Lancet 2005;366:1432. [Ref.ID 75175]

16.

Wise R. Antibiotics for acute infective conjunctivitis in children. Lancet 2005;366:1431-2. [Ref.ID 75174]

17.

Rose PW, Harnden A, Brueggemann AB, Perera R, Mant D. Antibiotics for acute infective conjunctivitis in children. In reply. Lancet 2005;366:1431. [Ref.ID 75173]

18.

Bunting H, Muthiah N, Fielder AR. Antibiotics for acute infective conjunctivitis in children. Lancet 2005;366:1431. [Ref.ID 75172]

19.

McGhee CNJ, Dean S, Danesh-Meyer H. Locally administered ocular corticosteroids: benefits and risks. Drug Saf 2002;25:33-55. [Ref.ID 60721]

20.

Anónimo. Pharmacia's Xalacom launched in EC. Scrip 2001;2689:24. [Ref.ID 58919]